The combination of diagnosis of pancreatic cancer marker, application and its measuring method

The combination of diagnosis of pancreatic cancer marker, application and its measuring method

  • CN 105,572,276 B
  • Filed: 11/07/2014
  • Issued: 12/18/2018
  • Est. Priority Date: 11/07/2014
  • Status: Active Grant
First Claim
Patent Images

1. a kind of combination of diagnosis of pancreatic cancer marker, which is characterized in that it is blood plasma or serum otherness metabolin, including choline,1,5- dewatered grape sugar alcohol, 2,5- dihydroxy-benzoic acid, talose, proline, glutamate, tryptophan, glutamine, beetAlkali, 2-oxoglutaric acid, methylguanidine, adenine, glycocholic acid, valine, 2-amino-butyric acid;

  • Wherein glutamate can use glutamateInstead of.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×